Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy-Reference-Cited by-同舟云学术

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

Published:2013-02-20 Issue:23 Volume:34 Page:1708-1713
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Agewall Stefan¹,Cattaneo M.²,Collet J.P.³,Andreotti F.⁴,Lip G.Y.H.⁵,Verheugt F.W.A.⁶,Huber K.⁷,Grove E.L.⁸,Morais J.⁹,Husted S.¹⁰,Wassmann S.¹¹,Rosano G.¹²,Atar D.¹,Pathak A.¹³,Kjeldsen K.¹⁴,Storey R.F.¹⁵,

Affiliation:

1. Department of Cardiology, Oslo University Hospital, Oslo University, Oslo, Norway

2. Medicina 3, Ospedale San Paolo. Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy

3. Université Pierre et Marie Curie-INSERM U 937 Institut de Cardiologie Groupe Hospitalier Pitié-Salpêtrière (APHP) 47-83, Bd de l'hopital, 75013, Paris, France

4. Department of Cardiovascular Sciences, Catholic University Hospital, Rome, Italy

5. University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom

6. Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam, Netherlands

7. 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria

8. Department of Cardiology, Aarhus University Hospital, Skejby, Denmark

9. Serviço de Cardiologia, Centro Hospitalar Leiria Pombal, Leiria, Portugal

10. Department of Cardiology, Århus University Hospital, Århus, Denmark

11. Department of Cardiology, Isar Heart Center, Isar Kliniken, Munich, Germany

12. Department of Medical Sciences, IRCCS San Raffaele Pisana, Via della Pisana, 235 Roma, Italy

13. CHU et Faculté de Médecine de Toulouse, Institut des Maladies Métaboliques et Cardiovasculaires (U104), Institut National de la Santé et de la Recherche Médicale, Université Toulouse III Paul Sabatier, Toulouse, France

14. The Heart Centre, Copenhagen University Hospital (Rigshospitalet) and The Faculty of Medicine, Aalborg University, Copenhagen and Aalborg, Denmark

15. Department of Cardiovascular Science, University of Sheffield, Sheffield, UK

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/34/23/1708/17895194/eht042.pdf

Reference53 articles.

1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Hamm;Eur Heart J,2011

2. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC);Steg;Eur Heart J,2012

3. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use;Abraham;. J Am Coll Cardiol,2010

4. Influence of omeprazol on the antiplatelet action of clopidogrel associated to ASA;Gilard;J Thromb Haemost,2006